![Daniel Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Gold
Directeur/Membre du Conseil chez
The Hope Funds for Cancer Research
Profil
Daniel P.
Gold is the founder of MMRGlobal, Inc. (founded in 2000) and Favrille, Inc. (founded in 2000).
At MMRGlobal, Inc. and Favrille, Inc., he held various titles.
Currently, he is a Trustee at The Hope Funds for Cancer Research.
Previously, he was the President & Chief Executive Officer at Prospect Therapeutics, Inc. (2008-2009), a Director at MEI Pharma, Inc. (2010-2023), a Managing Partner at Theragence, Inc. (2009-2010), and an Associate Professor at Sidney Kimmel Cancer Center (1992-2003).
He received his undergraduate degree from the University of California, Los Angeles and his doctorate from Tufts University.
Postes actifs de Daniel Gold
| Sociétés | Poste | Début |
|---|---|---|
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services Provides funds for cancer research | Directeur/Membre du Conseil | 21/10/2011 |
Anciens postes connus de Daniel Gold
| Sociétés | Poste | Fin |
|---|---|---|
| LITE STRATEGY, INC. | Directeur Général | 15/04/2011 |
Theragence, Inc.
 Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Corporate Officer/Principal | 01/04/2010 |
Favrille, Inc.
 Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Fondateur | 22/04/2009 |
Prospect Therapeutics, Inc.
 Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Directeur Général | 01/05/2009 |
Sidney Kimmel Cancer Center
 Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Provides medical research services | Corporate Officer/Principal | 01/01/2003 |
Formation de Daniel Gold
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Favrille, Inc.
Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Health Technology |
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Cancer Center
Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Provides medical research services | Health Services |
Prospect Therapeutics, Inc.
Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Health Technology |
MMRGlobal, Inc.
 MMRGlobal, Inc. Information Technology ServicesTechnology Services Provides electronic document management and online personal health record and storage solutions | Technology Services |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services Provides funds for cancer research | Commercial Services |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Health Technology |
